U-M startup Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
May 16, 2025
May 16, 2025
ANN ARBOR, Michigan, May 16 -- The University of Michigan posted the following news:
* * *
U-M startup Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
New melanocortin medicines target obesity and restrictive eating disorders and are synergistic with GLP-1s
University of Michigan spinout company Courage Therapeutics, which is developing medications for eating disorders and obesity, has received a seed investm . . .
* * *
U-M startup Courage Therapeutics receives $7.8M investment to advance weight regulation drugs
New melanocortin medicines target obesity and restrictive eating disorders and are synergistic with GLP-1s
University of Michigan spinout company Courage Therapeutics, which is developing medications for eating disorders and obesity, has received a seed investm . . .